4//SEC Filing
Astle Christopher 4
Accession 0000899243-22-038516
CIK 0001937653other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 8:00 PM ET
Size
10.6 KB
Accession
0000899243-22-038516
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Astle Christopher
SVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-12+1,550→ 2,220 total - Exercise/Conversion
Restricted Stock Unit
2022-12-12−1,550→ 1,550 total→ Common Shares (1,550 underlying) - Sale
Common Stock
2022-12-12$6.01/sh−887$5,331→ 1,333 total
Footnotes (5)
- [F1]Represents shares of common stock issued upon vesting of one half of the restricted stock units ("RSUs") granted on December 10, 2021.
- [F2]Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (the "Grant Agreement"), effective on the grant date of the RSUs, the Reporting Person adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.99 to $6.035, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F4]Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F5]The RSUs were granted on December 10, 2021 and vest in two equal annual instalments beginning on December 12, 2022.
Documents
Issuer
Zymeworks Inc.
CIK 0001937653
Entity typeother
Related Parties
1- filerCIK 0001915257
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 8:00 PM ET
- Size
- 10.6 KB